top of page

Frequency Therapeutics Welcome!

CreaGen Life Science Incubator team wishes a warm welcome to our new resident, Frequency Therapeutics! We are excited to have your team joining our incubator family.

Frequency Therapeutics is a platform technology that is based on discoveries in stem cell biology by Robert S. Langer at MIT and Jeff Karp at Harvard Medical School. Frequency Therapeutics initial focus is on chronic hearing loss, a potential $10B+ US market with no effective therapeutic solution. Other potential applications include gastrointestinal diseases and diabetes.

Featured Posts

Join us for the Vendors Exhibition at C2I Accelerator: Wed, May 22, 2024; 11 AM-1 PM

Join us for the Vendors Exhibition at C2I Accelerator: Wed, May 22, 2024; 11 AM-1 PM

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

Recent Posts

Join us for the Vendors Exhibition at C2I Accelerator: Wed, May 22, 2024; 11 AM-1 PM

C2I Family's 2023 Social Event Memories

We are excited to welcome our new member, Analog Devices!

Welcome to our member, 100X Bioassay!

We are extending a warm welcome to our new member, Fieldstone Bio, Inc.!

C2I Accelerator 2023 Summer Mixer

Bioactivity Supports Premature Infants’ Immunity, Development, and Growth, According to a Review

ODDITY Invests $100M to Bring Revela's AI-Based Molecule Discovery Technology to Beauty and Wellness

Thank you for attending our panel discussion, Strategies to Advance Startups in Today's Environment!

Save the Date: Strategies to Advance Startups in Today's Environment

Follow Us

bottom of page